Age ( in years ) |
Total Patients n=292 |
Males n=152 |
Females n=140 |
<2 |
18 (6.16%) |
11 |
7 |
2-5 |
54 (18.49%) |
29 |
25 |
5-10 |
124 (42.46%) |
67 |
57 |
10-15 |
96 (32.87%) |
45 |
51 |
Clinical features |
No of patients |
% |
Fever |
292 |
100% |
Vomiting |
144 |
49.31% |
Diarrhea |
108 |
36.98% |
Anorexia, malaise, bodyache And headache |
124 |
42.46% |
Cough |
98 |
33.56% |
Altered sensorium |
8 |
2.73% |
Convulsion |
6 |
2.05% |
Hepatomegaly |
210 |
71.91% |
Splenomegaly |
103 |
35.27% |
Coated Tongue |
42 |
14.38% |
Clinical features |
No of patients |
% |
Fever |
292 |
100% |
Vomiting |
144 |
49.31% |
Diarrhea |
108 |
36.98% |
Anorexia, malaise, bodyache And headache |
124 |
42.46% |
Cough |
98 |
33.56% |
Altered sensorium |
8 |
2.73% |
Convulsion |
6 |
2.05% |
Hepatomegaly |
210 |
71.91% |
Splenomegaly |
103 |
35.27% |
Coated Tongue |
42 |
14.38% |
Diagnostic Tests |
Done |
Positive |
Serum Widal |
292 |
292(100%) |
Blood Culture |
15 |
4(26.66%) |
Stool Culture |
3 |
2(66.66%) |
Antibiotics Given |
No of cases |
% |
Inj.Ceftraixone alone |
227 |
77.73% |
Inj.Ceftriaxone+oral azithromycin for 5 days |
62 |
21.23% |
Other drugs |
3 |
1.02% |
Duration of
hospitalization |
No of patients |
% |
<3 days |
52 |
17.80% |
3-6 days |
70 |
23.97% |
6-9 days |
158 |
54.10% |
>9 days |
12 |
4.10% |